Product Images Amlodipine Besylate
View Photos of Packaging, Labels & Appearance
- pdp - 68071 3698 9
- Amlodipine Besylate - 99f197ee 0a14 4981 a816 a1570a5a8da7 01
- Figure 1 - Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo - 99f197ee 0a14 4981 a816 a1570a5a8da7 02
- Figure 2 - Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups - 99f197ee 0a14 4981 a816 a1570a5a8da7 03
Product Label Images
The following 4 images provide visual information about the product associated with Amlodipine Besylate NDC 68071-3698 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
pdp - 68071 3698 9
This text provides detailed information about a medication called Amlodipine Besylate 10mg tablets, including the manufacturer, lot number, expiration date, physical description, dosage information, and safety warnings. It also includes instructions to consult a doctor for medical advice and how to report side effects to the FDA. Additionally, there is a warning to keep the medication out of reach of children and store it at a controlled temperature between 68-77°F.*
Amlodipine Besylate - 99f197ee 0a14 4981 a816 a1570a5a8da7 01
Figure 1 - Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo - 99f197ee 0a14 4981 a816 a1570a5a8da7 02
The text provides information about an event rate analysis comparing Amlodipine versus Placebo through Kaplan-Meier Analysis. It includes a p-value of 0.003, a hazard ratio of 0.691, and a 95% confidence interval ranging from 0.54 to 0.88. The data is presented graphically in Figure 1, showing the composite clinical outcomes over time (measured in months) for Amlodipine and Placebo.*
Figure 2 - Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups - 99f197ee 0a14 4981 a816 a1570a5a8da7 03
This document outlines a comparison between the effects of Amlodipine and Placebo in a study involving 1318 patients. The analysis includes data related to gender distribution, baseline systolic blood pressure, the presence of vessel disease and stenosis, and the use of PCI with or without stent placement. Additionally, it reports hazard ratios with 95% confidence intervals for the studied parameters.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
